Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
DBS bij patiënten met Parkinson en gedragsproblemen
aug 2018 | Bewegingsstoornissen